On August 17, 2006, the 10th U.S. Circuit Court of Appeals in Denver ruled the U.S. Food and Drug Administration correctly followed a mandate from Congress to analyze the risks and benefits of a product; the agency determined that there is no acceptable dosage level of ephedrine-alkaloid dietary supplements.
The FDA banned ephedrine-based supplements as of April 12, 2004, after finding that more than 150 deaths may have been linked to the herb.
The ban was challenged in a lawsuit filed in May 2004 by Nutraceutical Corp. and subsidiary Solaray Inc. They said the type of dried whole-herb ephedra sinica supplement used in their products had been safely used for thousands of years and they asked for a repeal of the nationwide ban or compensation for financial losses.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.